BNP Paribas Asset Management
ABVX

BNP Paribas Asset Management’s Abivax ABVX Stock Holding History

BNP Paribas Asset Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.51M Buy
49,516
+24,710
+100% +$2.92M 0.01% 838
2025
Q4 		$3.35M Buy
+24,806
New +$2.71M ﹤0.01% 939

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return

BNP Paribas Asset Management's ABVX Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Abivax (ABVX) stake by 100% in Q1 2026, buying an estimated $2.92M and bringing the position to 49,516 shares worth $5.51M. The position accounts for 0.01% of the portfolio, ranked #838.

BNP Paribas Asset Management first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • BNP Paribas Asset Management held 49,516 shares of Abivax worth $5.51M as of Q1 2026.
  • BNP Paribas Asset Management bought 24,710 Abivax shares in Q1 2026, an estimated $2.92M.
  • Abivax made up 0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #838 holding.
  • BNP Paribas Asset Management first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.